OLD-TAVR score to predict 2-year mortality in patients aged 75 years and more undergoing transcatheter aortic valve replacement
- PMID: 37165292
- DOI: 10.1007/s41999-023-00794-x
OLD-TAVR score to predict 2-year mortality in patients aged 75 years and more undergoing transcatheter aortic valve replacement
Abstract
Purpose: Decision-making on transcatheter aortic valve replacement (TAVR) in patients aged 75 years and older is complex. It could be facilitated by the identification of predictors of long-term mortality. This study aimed to identify predictors of 2-year mortality to develop a 2-year mortality risk score.
Methods: Cohort study of consecutive patients aged ≥ 75 years who underwent TAVR after a comprehensive geriatric assessment (CGA) at our university hospital between 2012 and 2019. Predictors of 2-year mortality were determined using multivariable Cox regression. A point-based predictive model was developed based on risk factors and subsequently internally validated by fivefold cross-validation.
Results: The 345 patients (median age 87 years, 54% women) were fit/vulnerable (32%), mildly frail (37%), or moderately/severely frail (31%). The overall 2-year mortality rate was 26%, predicted by atrial fibrillation, hemoglobin ≤ 10 g/dL, age ≥ 87 years, BMI ≤ 24, eGFR ≤ 50 ml/min, and moderate/severe frailty. The risk score (range 0-12), named OLD-TAVR score, for 2-year mortality showed good discriminative power (AUC 0.70) and remained consistent after fivefold cross-validation (cvAUC 0.69). A risk score ≥ 8 (prevalence 20%) predicted a 45% (95%CI: 34-58%) two-year mortality, with high specificity (86%) and good positive predictive power (+ LR 2.43).
Conclusion: A 2-year mortality risk score (OLD-TAVR score) for very old patients undergoing TAVR was developed based on six bio-clinical items. A score ≥ 8 identified patients in whom 2-year mortality was very high and thereby the TAVR futile.
Trial registration number and date of registration: Study protocol B403, 26/09/2022, retrospectively registered.
Keywords: Aortic stenosis; CFS; Frailty; Older adults; Risk score; TAVR.
© 2023. The Author(s), under exclusive licence to European Geriatric Medicine Society.
References
-
- Yamamoto M, Mouillet G, Meguro K, Gilard M, Laskar M, Eltchaninoff H et al (2014) Clinical results of transcatheter aortic valve implantation in octogenarians and nonagenarians: insights from the FRANCE-2 registry. Ann Thorac Surg 97:29–36. https://doi.org/10.1016/j.athoracsur.2013.07.100 - DOI - PubMed
-
- Noguchi M, Tabata M, Obunai K, Shibayama K, Ito J, Watanabe H et al (2021) Clinical outcomes of transcatheter aortic valve implantation (TAVI) in nonagenarians from the optimized catheter valvular intervention - TAVI registry. Catheter Cardiovasc Interv. https://doi.org/10.1002/ccd.28935 - DOI - PubMed - PMC
-
- Habertheuer A, Aranda-Michel E, Schindler J, Gleason TG, Kilic A, Kliner D et al (2021) Longitudinal outcomes of nonagenarians undergoing transcatheter aortic valve replacement. Ann Thorac Surg 111:1520–1528. https://doi.org/10.1016/j.athoracsur.2020.06.140 - DOI - PubMed
-
- Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J et al (2022) 2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Rev Esp Cardiol Engl Ed 75:524. https://doi.org/10.1016/j.rec.2022.05.006 - DOI - PubMed
-
- Nashef SAM, Roques F, Sharples LD, Nilsson J, Smith C, Goldstone AR et al (2012) EuroSCORE II. Eur J Cardiothorac Surg 41:734–745. https://doi.org/10.1093/ejcts/ezs043 - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous